Log on / register
Feedback | Support | My details
Open AccessResearch article

Genomic characterisation, chromosomal assignment and in vivo localisation of the canine High Mobility Group A1 (HMGA1) gene

Claudia Beuing* 1 email, Jan T Soller* 1,2 email, Michaela Muth2 email, Sigfried Wagner2 email, Gaudenz Dolf3 email, Claude Schelling4 email, Andreas Richter2 email, Saskia Willenbrock1,2 email, Nicola Reimann-Berg1,2 email, Susanne Winkler2 email, Ingo Nolte1 email, Jorn Bullerdiek1,2 email and Hugo Murua Escobar1,2 email

1Clinic for Small Animals and Research Cluster of Excellence "REBIRTH", University of Veterinary Medicine Hanover, Bischofsholer Damm 15, 30173 Hanover, Germany

2Centre for Human Genetics, University of Bremen, Leobener Str ZHG, 28359 Bremen, Germany

3Institute of Animal Genetics, Nutrition and Housing, University of Berne, Berne, Switzerland

4Department of Animal Sciences, Swiss Federal Institute of Technology Zurich and Vetsuisse Faculty Zurich, University of Zurich, Zurich, Switzerland

author email corresponding author email* Contributed equally

BMC Genetics 2008, 9:49doi:10.1186/1471-2156-9-49

Published: 23 July 2008

Abstract

Background

The high mobility group A1 proteins (HMGA1a/HMGA1b) are highly conserved between mammalian species and widely described as participating in various cellular processes. By inducing DNA conformation changes the HMGA1 proteins indirectly influence the binding of various transcription factors and therefore effect the transcription regulation. In humans chromosomal aberrations affecting the HMGA1 gene locus on HSA 6p21 were described to be the cause for various benign mesenchymal tumours while high titres of HMGA1 proteins were shown to be associated with the neoplastic potential of various types of cancer. Interestingly, the absence of HMGA1 proteins was shown to cause insulin resistance and diabetes in humans and mice.

Due to the various similarities in biology and presentation of human and canine cancers the dog has joined the common rodent animal model for therapeutic and preclinical studies. Accordingly, the canine genome was sequenced completely twice but unfortunately this could not solve the structure of canine HMGA1 gene.

Results

Herein we report the characterisation of the genomic structure of the canine HMGA1 gene consisting of 7 exons and 6 introns spanning in total 9524 bp, the in vivo localisation of the HMGA1 protein to the nucleus, and a chromosomal assignment of the gene by FISH to CFA12q11. Additionally, we evaluated a described canine HMGA1 exon 6 SNP in 55 Dachshunds.

Conclusion

The performed characterisations will make comparative analyses of aberrations affecting the human and canine gene and proteins possible, thereby providing a basis for revealing mechanisms involved in HMGA1 related pathogenesis in both species.


© 1999-2008 BioMed Central Ltd unless otherwise stated